Investing Ideas
/
Hong Kong Pharmaceuticals & Biotech Undiscovered Gems With Strong Fundamentals

Hong Kong Pharmaceuticals & Biotech Undiscovered Gems With Strong Fundamentals

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

0 new

High-performing small cap companies that haven't yet garnered significant analyst attention, and could lead to superior returns.

8 companies

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
2161 JBM (Healthcare)	HK$1.90	-0.5%	95.9%	HK$1.5b	n/a	PE9.4x	n/a	5.8%
2566 Hangzhou Jiuyuan Gene Engineering	HK$5.84	3.4%	n/a	HK$1.4b	n/a	PE10.4x	n/a	n/a
2348 Dawnrays Pharmaceutical (Holdings)	HK$1.20	0%	8.1%	HK$1.8b	n/a	PE3x	n/a	6.5%
2633 Jacobson Pharma	HK$1.26	-1.6%	113.6%	HK$2.5b	n/a	PE9.9x	n/a	5.6%
1558 YiChang HEC ChangJiang Pharmaceutical	HK$9.19	0.4%	11.8%	HK$8.1b	HK$12.59	PE4.6x	S-1.2%	0%
1061 Essex Bio-Technology	HK$2.88	2.5%	20.0%	HK$1.6b	HK$5.12	PE6.2x	E6.2%	4.2%
6826 Shanghai Haohai Biological Technology	HK$24.80	-0.6%	6.8%	HK$12.7b	HK$42.57	PE12.3x	E16.8%	3.5%
1681 Consun Pharmaceutical Group	HK$7.87	0%	48.5%	HK$6.5b	HK$10.20	PE7.3x	E14.7%	7.4%

Page 1 of 1